Johann Bauersachs - Selected Publications#

Bauersachs J, Soltani S. Sodium-glucose co-transporter 2 inhibitors and mineralocorticoid receptor antagonists synergism in heart failure: it takes two to tango. Eur Heart J 2023; doi: 10.1093/eurheartj/ehad540 (IF EHJ= 39,3)

Jackson AM, *Bauersachs J, Petrie MC, van der Meer P, …., Maggioni AP, Briton O, Sliwa K; EurObservational Research Programme in conjunction with the HFA of the ESC Study Group on Peripartum Cardiomyopathy. Outcomes at one year in women with peripartum cardiomyopathy: findings from the ESC EORP PPCM Registry. Eur J Heart Fail 2023; doi: 10.1002/ejhf.3055 (IF EJHF= 18,2)

Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Filippatos G, Gustafsson F, Lam CSP, Lund LH, Mentz RJ, Pieske B, Ponikowski P, Senni M, Skopicki N, Voors AA, Zannad F, Zieroth S, Butler J. Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3. J Am Coll Cardiol. 2023;82(6):559-571. doi: 10.1016/j.jacc.2023.04.057. (IF J Am Coll Cardiol= 24,4)

Mullens W, Schulze PC, Westphal J, Bogoviku J, Bauersachs J. Great Debate: In patients with decompensated heart failure Acetazolamide in addition to loop diuretics is the first choice. EurHeart J. 2023; 44(24):2159-2169. doi: 10.1093/eurheartj/ehad266

van Veldhuisen D, Bauersachs J. Digitalis in Heart Failure: declining use and ongoing outcome trials. Eur Heart J 2023, doi: 10.1093/eurheartj/ehad185 (IF EHJ= 39,3)

Frantz S, Hundertmark M, Schulz-Menger J, Bengel F, Bauersachs J. Left ventricular remodelling post myocardial infarction: pathophysiology, imaging and novel therapies. Eur Heart J. 2022, ehac223. doi: 10.1093/eurheartj/ehac223. (IF EHJ= 39,3)

Reboll MR, Klede S, Taft MH, Cai CL, Field LJ, …, van den Heuvel J, Pich A, Bauersachs J, Wu X, Zheng L, Wang Y, Korf-Klingebiel M, Polten F, Wollert KC. Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase. Science 2022;376(6599):1343-1347. doi:10.1126/science.abn3027. (IF= 56,9)

Diekmann J, Koenig T, Zwadlo C, Derlin T, Neuser J, Thackeray JT, Schäfer A, Ross TL, Bauersachs J, Bengel FM. Molecular Imaging Identifies Fibroblast Activation Beyond the Infarct Region After Acute Myocardial Infarction. J Am Coll Cardiol. 2021;77:1835-1837. doi: 10.1016/j.jacc.2021.02.019. (IF J Am Coll Cardiol= 24,4)

Sliwa K, Petrie MC, van der Meer P, Mebazaa A, Hilfiker-Kleiner D, Jackson AM, Maggioni AP, Laroche C, Regitz-Zagrosek V, …., Ponikowski P, Van Veldhuisen DJ, McMurray J, Bauersachs J. Clinical presentation, management and 6-month outcomes in women with peripartum cardiomyopathy, an ESC EORP registry. Eur Heart J 2020, doi: 10.1093/eurheartj/ehaa455 (IF EHJ= 39,3)

Bauersachs J, König T, van der Meer P, Petrie MC, Hilfiker-Kleiner D, …, Anker SD, Ponikowski P, Seferovic PM, Johnson MR, Mebazaa A, Sliwa K. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the HFA of the ESC Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019. doi: 10.1002/ejhf.1493. (IF EJHF= 18,2)

Bavendiek U, Berliner D, Aguirre Dávila L, …, v. d. Leyen H, Schröder C, Veltmann C, Störk S, Böhm M, Koch A, Bauersachs J. Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study. Eur J Heart Fail, 2019 21(5):676-684. doi: 10.1002/ejhf.1452 (IF EJHF= 18,2)

h-index (Google Scholar) 127
h-index (Web of Science) 102